Payment overview · 2025
General Payments
$16.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
Ahmad Wardeh, MD
Allopathic & Osteopathic Physicians|Internal Medicine · RANSHAW, PA · NPI 1255309779
Verified facts
What the public records show
CMS Open Payments records show Ahmad Wardeh, MD received $16.96 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $16.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FASENRA Normalized: fasenra |
Biological | AstraZeneca Pharmaceuticals LP | $16.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 760 | 148 |
| Atorvastatin Calcium | Atorvastatin Calcium | 755 | 163 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 662 | 148 |
| Omeprazole | Omeprazole | 626 | 131 |
| Metoprolol Succinate | Metoprolol Succinate | 610 | 133 |
| Lisinopril | Lisinopril | 439 | 99 |
| Gabapentin | Gabapentin | 407 | 68 |
| Sertraline Hcl | Sertraline Hcl | 388 | 67 |
| Furosemide | Furosemide | 380 | 78 |
| Duloxetine Hcl | Duloxetine Hcl | 349 | 85 |
| Oxycodone Hcl | Oxycodone Hcl | 336 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 313 | 54 |
| Warfarin Sodium | Warfarin Sodium | 296 | 15 |
| Amlodipine Besylate | Amlodipine Besylate | 280 | 66 |
| Jardiance | Empagliflozin | 253 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 236 | 50 |
| Alprazolam | Alprazolam | 225 | 47 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 225 | 32 |
| Losartan Potassium | Losartan Potassium | 214 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 206 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 204 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 190 | 53 |
| Famotidine | Famotidine | 188 | 24 |
| Eliquis | Apixaban | 185 | 50 |
| Prednisone | Prednisone | 172 | 84 |
| Lorazepam | Lorazepam | 171 | 39 |
| Donepezil Hcl | Donepezil Hcl | 165 | 20 |
| Montelukast Sodium | Montelukast Sodium | 164 | 40 |
| Tramadol Hcl | Tramadol Hcl | 157 | 35 |
| Mirtazapine | Mirtazapine | 156 | 17 |
| Ozempic | Semaglutide | 152 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 148 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 143 | 30 |
| Xarelto | Rivaroxaban | 136 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 134 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 134 | 25 |
| Trazodone Hcl | Trazodone Hcl | 131 | 36 |
| Allopurinol | Allopurinol | 130 | 22 |
| Potassium Chloride | Potassium Chloride | 130 | 28 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 124 | 33 |
| Pregabalin | Pregabalin | 123 | 26 |
| Metformin Hcl | Metformin Hcl | 121 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 118 | 25 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 115 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 114 | 26 |
| Propranolol Hcl | Propranolol Hcl | 108 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 103 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 102 | 22 |
| Topiramate | Topiramate | 95 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 94 | 29 |
| Carvedilol | Carvedilol | 93 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 92 | 27 |
| Ezetimibe | Ezetimibe | 89 | 11 |
| Aripiprazole | Aripiprazole | 88 | 25 |
| Azithromycin | Azithromycin | 82 | 70 |
| Memantine Hcl | Memantine Hcl | 82 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 75 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 74 | 22 |
| Nystatin | Nystatin | 73 | 33 |
| Nitroglycerin | Nitroglycerin | 72 | 41 |
| Finasteride | Finasteride | 70 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 66 | 29 |
| Levetiracetam | Levetiracetam | 65 | 13 |
| Clonazepam | Clonazepam | 64 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 64 | 16 |
| Tradjenta | Linagliptin | 62 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 60 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 60 | 49 |
| Diazepam | Diazepam | 60 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 59 | 12 |
| Torsemide | Torsemide | 59 | 14 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | suppressed |
| Atenolol | Atenolol | 55 | 14 |
| Bethanechol Chloride | Bethanechol Chloride | 55 | suppressed |
| Trulicity | Dulaglutide | 55 | suppressed |
| Risperidone | Risperidone | 54 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 53 | suppressed |
| Creon | Lipase/Protease/Amylase | 52 | suppressed |
| Digoxin | Digoxin | 52 | suppressed |
| Myrbetriq | Mirabegron | 52 | suppressed |
| Multaq | Dronedarone Hcl | 51 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 51 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | 13 |
| Meloxicam | Meloxicam | 49 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 39 |
| Glimepiride | Glimepiride | 48 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 48 | suppressed |
| Celecoxib | Celecoxib | 47 | 23 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 47 | suppressed |
| Carbamazepine | Carbamazepine | 46 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 46 | 12 |
| Movantik | Naloxegol Oxalate | 46 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | 11 |
| Gemtesa | Vibegron | 44 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 44 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 43 | suppressed |
| Simvastatin | Simvastatin | 43 | 12 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 11 |
| Fentanyl | Fentanyl | 41 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 41 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 40 | 12 |
| Valsartan | Valsartan | 40 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 21 |
| Naproxen | Naproxen | 39 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 38 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 37 | suppressed |
| Novolog Flexpen | Insulin Aspart | 36 | 13 |
| Spironolactone | Spironolactone | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | suppressed |
| Olanzapine | Olanzapine | 35 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 34 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 33 | 11 |
| Risedronate Sodium | Risedronate Sodium | 32 | suppressed |
| Amantadine | Amantadine Hcl | 31 | suppressed |
| Gemfibrozil | Gemfibrozil | 31 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 30 | 11 |
| Hydromorphone Hcl | Hydromorphone Hcl | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Colchicine | Colchicine | 29 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 25 |
| Divalproex Sodium | Divalproex Sodium | 27 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 23 | suppressed |
| Jantoven | Warfarin Sodium | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 18 |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 14 |
| Bumetanide | Bumetanide | 22 | suppressed |
| Felodipine Er | Felodipine | 22 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 22 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 19 | 13 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 18 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Niacin Er | Niacin | 18 | suppressed |
| Vascepa | Icosapent Ethyl | 18 | suppressed |
| Carbamazepine Er | Carbamazepine | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Mesalamine | Mesalamine | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Methadone Hcl | Methadone Hcl | 14 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 14 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 13 |
| Sucralfate | Sucralfate | 14 | suppressed |
| Verapamil Sr | Verapamil Hcl | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | 13 |
| Colesevelam Hcl | Colesevelam Hcl | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 11 |
| Prolia | Denosumab | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 11 |
| Eplerenone | Eplerenone | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.96 · 1 records | AstraZeneca Pharmaceuticals LP | FASENRA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error